vs

Side-by-side financial comparison of ADC Therapeutics SA (ADCT) and Farmmi, Inc. (FAMI). Click either name above to swap in a different company.

ADC Therapeutics SA is the larger business by last-quarter revenue ($23.1M vs $16.1M, roughly 1.4× Farmmi, Inc.). On growth, ADC Therapeutics SA posted the faster year-over-year revenue change (36.4% vs -55.7%).

ADC Telecommunications, Inc. was a communications company in Eden Prairie, Minnesota, a southwest suburb of Minneapolis. It was acquired by TE Connectivity in December 2010 and ceased to exist as a separate entity. ADC products were sold by CommScope after it acquired the Broadband Network Solutions business unit from TE Connectivity in August 2015.

Farmmi Inc. is a company that processes and sells agricultural products in China and abroad; it grows and markets shiitake and wood ear mushrooms and other edible fungi products, including bamboo fungi, chestnut mushroom, trumpet royale, hen of the woods, lawyer's wig, and lion's mane mushroom. It also operates Farmmi Jicai, an online store that sells edible fungi products under the Forasen and Farmmi Liangpin brands. In addition, the company exports dried whole and sliced shiitake mushrooms,...

ADCT vs FAMI — Head-to-Head

Bigger by revenue
ADCT
ADCT
1.4× larger
ADCT
$23.1M
$16.1M
FAMI
Growing faster (revenue YoY)
ADCT
ADCT
+92.1% gap
ADCT
36.4%
-55.7%
FAMI

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ADCT
ADCT
FAMI
FAMI
Revenue
$23.1M
$16.1M
Net Profit
$-44.0K
Gross Margin
5.0%
Operating Margin
-77.7%
-4.1%
Net Margin
-0.3%
Revenue YoY
36.4%
-55.7%
Net Profit YoY
-107.0%
EPS (diluted)
$0.04
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADCT
ADCT
FAMI
FAMI
Q4 25
$23.1M
Q3 25
$15.8M
Q2 25
$18.1M
Q1 25
$17.4M
$16.1M
Q4 24
$16.9M
Q3 24
$18.0M
Q2 24
$17.0M
Q1 24
$17.8M
$36.4M
Net Profit
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
$-41.0M
Q2 25
$-56.6M
Q1 25
$-38.6M
$-44.0K
Q4 24
Q3 24
$-44.0M
Q2 24
$-36.5M
Q1 24
$-46.6M
$630.5K
Gross Margin
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
Q2 25
Q1 25
5.0%
Q4 24
Q3 24
Q2 24
Q1 24
5.9%
Operating Margin
ADCT
ADCT
FAMI
FAMI
Q4 25
-77.7%
Q3 25
-196.6%
Q2 25
-244.1%
Q1 25
-163.5%
-4.1%
Q4 24
-191.8%
Q3 24
-197.4%
Q2 24
-170.5%
Q1 24
-188.3%
2.5%
Net Margin
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
-260.1%
Q2 25
-313.2%
Q1 25
-221.8%
-0.3%
Q4 24
Q3 24
-244.1%
Q2 24
-214.6%
Q1 24
-261.1%
1.7%
EPS (diluted)
ADCT
ADCT
FAMI
FAMI
Q4 25
$0.04
Q3 25
$-0.30
Q2 25
$-0.50
Q1 25
$-0.36
$-0.04
Q4 24
$-0.26
Q3 24
$-0.42
Q2 24
$-0.38
Q1 24
$-0.56
$1.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADCT
ADCT
FAMI
FAMI
Cash + ST InvestmentsLiquidity on hand
$261.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-185.8M
$166.4M
Total Assets
$323.1M
$230.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADCT
ADCT
FAMI
FAMI
Q4 25
$261.3M
Q3 25
$234.7M
Q2 25
$264.6M
Q1 25
$194.7M
Q4 24
$250.9M
Q3 24
$274.3M
Q2 24
$300.1M
Q1 24
$234.3M
Stockholders' Equity
ADCT
ADCT
FAMI
FAMI
Q4 25
$-185.8M
Q3 25
$-238.2M
Q2 25
$-199.2M
Q1 25
$-238.2M
$166.4M
Q4 24
$-202.6M
Q3 24
$-171.9M
Q2 24
$-131.7M
Q1 24
$-194.4M
$164.4M
Total Assets
ADCT
ADCT
FAMI
FAMI
Q4 25
$323.1M
Q3 25
$289.8M
Q2 25
$321.6M
Q1 25
$272.5M
$230.4M
Q4 24
$322.0M
Q3 24
$349.1M
Q2 24
$371.8M
Q1 24
$308.0M
$171.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADCT
ADCT
FAMI
FAMI
Operating Cash FlowLast quarter
$-31.1M
$14.6M
Free Cash FlowOCF − Capex
$14.6M
FCF MarginFCF / Revenue
90.1%
Capex IntensityCapex / Revenue
0.0%
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADCT
ADCT
FAMI
FAMI
Q4 25
$-31.1M
Q3 25
$-29.6M
Q2 25
$-24.1M
Q1 25
$-56.3M
$14.6M
Q4 24
$-21.9M
Q3 24
$-25.0M
Q2 24
$-32.8M
Q1 24
$-44.1M
$-14.9M
Free Cash Flow
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
Q2 25
Q1 25
$-56.6M
$14.6M
Q4 24
$-21.9M
Q3 24
$-25.3M
Q2 24
$-32.9M
Q1 24
$-44.6M
FCF Margin
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
Q2 25
Q1 25
-325.2%
90.1%
Q4 24
-129.8%
Q3 24
-140.2%
Q2 24
-193.0%
Q1 24
-250.0%
Capex Intensity
ADCT
ADCT
FAMI
FAMI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
1.5%
0.1%
Q4 24
0.5%
Q3 24
1.2%
Q2 24
0.2%
Q1 24
3.0%
0.0%
Cash Conversion
ADCT
ADCT
FAMI
FAMI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
-23.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons